Piramal Pharma (PPLPHARMA) Share Price Falls 2.44%: What the Move Shows

Piramal Pharma Share Price is trading at Rs 189.70, down 2.44% today, with a market capitalisation of Rs 25,888.06 crore. The latest Piramal Pharma Share Price move took the stock below its previous close of Rs 194.45 after opening at Rs 194.70 and touching an intraday high of Rs 199.50 before slipping to the day’s low of Rs 189.70. Univest data confirms the move itself, though no company-specific trigger has been identified. For readers tracking Piramal Pharma Share Price Today, the movement matters because it combines a clear share price decline with valuation and profitability metrics that are worth reading together. This Piramal Pharma Stock News note focuses on what the price action shows, how the fundamentals compare with the Healthcare and pharmaceuticals peer set, and what investors should monitor next through Univest.

Piramal Pharma (PPLPHARMA) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 189.7
Previous Close	Rs 194.45
Today's Move	-Rs 4.75 (-2.44%)
Open	Rs 194.7
High	Rs 199.5
Low	Rs 189.7
Market Capitalisation	Rs 25,888.06 crore
Market Cap Category	Large Cap

Piramal Pharma Share Price Today reflects a single-session decline of Rs 4.75, or 2.44%, from the previous close of Rs 194.45 to Rs 189.70. The stock opened near the prior settlement at Rs 194.70, moved up to Rs 199.50, and then touched Rs 189.70, which is also the day low. That range shows Piramal Pharma Share Price was active across the morning band before settling near the lower end of the move. With a market capitalisation of Rs 25,888.06 crore, Piramal Pharma fits the Large Cap category in this article’s context. The Piramal Pharma Share Price fall is therefore best read as a price action event first, followed by a closer look at whether the valuation and return ratios add support or caution.

The Piramal Pharma Share Price Update does not stand alone. A fall of 2.44% in a Large Cap company draws attention because the market is still re-pricing the stock around current earnings and book-value inputs. That makes the next section on Piramal Pharma Fundamental Analysis important for context.

Piramal Pharma (PPLPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 25,888.06 crore
P/B Ratio	3.23x
ROE	-4.04%
ROCE	1.24%
EPS	Rs -2.36
Book Value Per Share	Rs 60.13
Dividend Yield	0%

Piramal Pharma (PPLPHARMA) fundamental metrics show P/B 3.23x, ROE -4.04%, ROCE 1.24%. Read together, these ratios describe the company's position rather than a recommendation.

Piramal Pharma has a market capitalisation of Rs 25,888.06 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 3.23x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -4.04% and ROCE of 1.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -2.36, book value per share of Rs 60.13, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.73x, median ROE of 11.33%, median ROCE of 13.25%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Benchmark Median P/E	31.73x
Benchmark Average P/E	45.98x
Benchmark P/E Range	3.1x to 616.89x
Company P/B Ratio	3.23x
Benchmark Median P/B	2.76x
Benchmark Average P/B	4.11x
Company ROE	-4.04%
Benchmark Median ROE	11.33%
Benchmark Average ROE	10.14%
Company ROCE	1.24%
Benchmark Median ROCE	13.25%
Benchmark Average ROCE	13.05%
Company Market Capitalisation	Rs 25,888.06 crore
Benchmark Median Market Cap	Rs 771.43 crore
Benchmark Average Market Cap	Rs 13,467.03 crore

Piramal Pharma (PPLPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Piramal Pharma (PPLPHARMA) has a ROE of -4.04%, which is below the benchmark median of 11.33%, a difference of -135.66%. Piramal Pharma (PPLPHARMA) has a ROCE of 1.24%, which is below the benchmark median of 13.25%, a difference of -90.64%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,18,683.95	34.61	4.84	14.85	19.11
Divi's Laboratories	DIVISLAB	2,41,310.94	82.5	13.66	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,73,078.79	79.36	19.28	26.76	19.27
Laurus Labs	LAURUSLABS	1,11,433.99	101.92	19.76	18.31	18.2
Zydus Lifesciences	ZYDUSLIFE	1,11,022.18	24.6	4.12	19.69	21.39

Its ROE of -4.04% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 1.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Piramal Pharma (PPLPHARMA) has a market capitalisation of Rs 25,888.06 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Piramal Pharma

• Piramal Pharma Share Price fell 2.44% to Rs 189.70, which puts today’s price action directly in focus for Univest readers.
• The stock’s P/B of 3.23 sits above the same-industry median of 2.76, so Piramal Pharma Share Price remains interesting on valuation context.
• ROE of -4.04% and ROCE of 1.24% keep profitability in view when reviewing Piramal Pharma Fundamental Analysis.
• EPS of -2.36, book value of Rs 60.13 and dividend yield of 0% provide a direct snapshot for Piramal Pharma Share Price Today.
• The Healthcare and Pharmaceuticals & Drugs sector comparison shows Piramal Pharma Share Price against a wide peer base of 199 companies.

About Piramal Pharma

Piramal Pharma operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is part of the Indian listed pharma universe tracked by Univest, where Piramal Pharma Share Price is assessed alongside peers on market capitalisation, valuation ratios and return metrics. In this note, the business is viewed through the financial lens available here: market value, P/B, EPS, book value, ROE and ROCE. That makes Piramal Pharma Stock News relevant for readers who want a factual read on price movement and a grounded view of the company’s listed financial profile.

Track Piramal Pharma Share Price on Univest

Use Piramal Pharma (PPLPHARMA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

You can track Piramal Pharma Share Price on Univest for live price movement, fundamental ratios, 52-week levels and market insights in one place. The same page helps readers follow Piramal Pharma Share Price Today, Piramal Pharma Stock News and broader company context without switching between sources. Univest also keeps the stock view tied to valuation, sector comparison and updated market data.

Frequently Asked Questions

Why is Piramal Pharma Share Price falling today?

Ans. Piramal Pharma Share Price is down 2.44% to Rs 189.70, with no company-specific catalyst established in the verified data. The move is confirmed by the day’s open, high, low and previous close.

What is Piramal Pharma Share Price today?

Ans. Piramal Pharma Share Price today is Rs 189.70, compared with the previous close of Rs 194.45. The stock moved between Rs 189.70 and Rs 199.50 during the day, keeping price action in focus.

What does Piramal Pharma Share Price tell investors?

Ans. Piramal Pharma Share Price shows a Large Cap company trading at Rs 25,888.06 crore in market value, with P/B at 3.23, EPS at -2.36, ROE at -4.04% and ROCE at 1.24%.

How does Piramal Pharma Share Price compare with the same industry?

Ans. Piramal Pharma Share Price has a P/B above the same-industry median of 2.76, but its ROE and ROCE are below the industry median and average. That comparison places the stock in a weaker return profile.

Is Piramal Pharma Share Price expensive on book value?

Ans. Piramal Pharma Share Price has a P/B of 3.23, which is above the same-industry median of 2.76 but below the average of 4.11. The book value per share is Rs 60.13, giving context to the current price.

What is the EPS linked to Piramal Pharma Share Price?

Ans. The EPS linked to Piramal Pharma Share Price is -2.36 in the latest figures used here. That negative EPS is one reason the stock’s profitability read deserves attention alongside valuation and sector context.

What are the ROE and ROCE for Piramal Pharma Share Price analysis?

Ans. Piramal Pharma Share Price analysis shows ROE at -4.04% and ROCE at 1.24%. Both are below the same-industry medians, so the return profile remains an important part of the stock’s current assessment.

Does Piramal Pharma Share Price have dividend support?

Ans. Piramal Pharma Share Price has a dividend yield of 0% in the latest Univest figures. That means the current analysis should focus on price action, valuation and profitability rather than any yield contribution.

How can investors track Piramal Pharma Share Price on Univest?

Ans. Investors can track Piramal Pharma Share Price on Univest for live movement, fundamental ratios, market capitalisation, 52-week levels and sector context. It gives a single view of price action and company fundamentals.